Cholecystokinin B antagonists. Synthesis and quantitative structure-activity relationships of a series of C-terminal analogues of CI-988

Bioorganic and Medicinal Chemistry

Volumn 4, Issue 10, 1996, Pages 1733-1745

  Augelli Szafran, Corinne E ^a   Horwell, David C ^b   Kneen, Clare ^b   Ortwine, Daniel F ^a   Pritchard, Martyn C ^b   Purchase, Terri S ^a   Roth, Bruce D ^a   Trivedi, Bharat K ^a   Hill, David ^c   Suman Chauhan, Nirmala ^b   Webdale, Louise ^b  

^a PFIZER INC   (United States)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 [[2 [2 [[(2 ADAMANTYLOXY)CARBONYL]AMINO] 3 (1H INDOL 3 YL) 2 METHYLPROPIONAMIDO] 1 PHENYLETHYL]AMINO] 4 OXOBUTYRIC ACID MEGLUMINE; CHOLECYSTOKININ B RECEPTOR; CHOLECYSTOKININ B RECEPTOR ANTAGONIST;

ANIMAL TISSUE; ARTICLE; DRUG ACTIVITY; DRUG SYNTHESIS; MOUSE; NONHUMAN; PHYSICAL CHEMISTRY; QUANTITATIVE STRUCTURE ACTIVITY RELATION; RAT; RECEPTOR AFFINITY;

ANIMALIA;

EID: 0344230147     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/0968-0896(96)00185-X     Document Type: Article

References (37)

1. 1. Mutt, V.; Jorpeo, J. E. Eur. J. Biochem. 1968, 6, 156.
2. 2. Innis, R. B.; Snyder, S. H. Proc. Natl. Acad. Sci. U.S.A. 1980, 77, 6917.
3. 3. (a) Hughes, J.; Boden, P.; Costall, B.; Domeney, A.; Kelly, E.; Horwell, D.; Hunter, J. C.; Pinnock, R. D.; Woodruff, G. N. Proc. Natl. Acad. Sci. U.S.A. 1990, 87, 6728.
4. (b) Rataud, J.; Darche, F.; Piot, O.; Stutzmann, J.-M.; Bohme, G. A.; Blanchard, J.-C. Brain Res. 1991, 548, 315.
5. (c) Singh, L.; Lewis, A. S.; Field, M. J.; Hughes, J.; Woodruff, G. N. Proc. Natl. Acad. Sci. U.S.A. 1991, 88, 1130.
6. 4. (a) Bradwejn, J.; Koszycki, D. In Multiple Cholecystokinin Receptors in the CNS; Dourish, C. T., et al., Eds.; Oxford University: Oxford, 1992; pp 121-131.
7. (b) Bradwejn, J.; Koszycki, D.; Couetoux du Tertre, A.; Bourin, M.; Palmour, R.; Ervin, F. J. Psychopharmacol. 1992, 6, 345.
8. 5. (a) Trivedi, B. K. Curr. Opin. Ther. Patents 1994, 4, 31.
9. (b) Trivedi, B. K. Curr. Med. Chem. 1994, 1, 313.
10. 6. (a) Horwell, D. C.; Hughes, J.; Hunter, J. C.; Pritchard, M. C.; Richardson, R. S.; Roberts, E.; Woodruff, G. N. J. Med. Chem. 1991, 34, 404.
11. (b) Bourne, G. T.; Horwell, D. C.; Pritchard, M. C. Tetrahedron 1991, 47, 4763.
12. (c) Singh, L.; Field, M. J.; Hughes, J.; Menzies, R.; Oles, R. J.; Vass, C. A.; Woodruff, G. N. Br. J. Pharmacol. 1991, 104, 239.
13. (d) Higginbottom, M.; Kneen, C.; Ratcliffe, G. S. J. Med. Chem. 1992, 35, 1572.
14. (e) Drysdale, M. J.; Pritchard, M. C.; Horwell, D. C. J. Med. Chem. 1992, 35, 2573.
15. (f) Drysdale, M. J.; Pritchard, M. C.; Horwell, D. C. Biorg. Med. Chem. Lett. 1992, 2, 45.
16. (g) Didier, E.; Horwell, D. C.; Pritchard, M. C. Tetrahedron 1992, 48, 8471.
17. (h) Bolton, G. L.; Roth, B. D.; Trivedi, B. K. Tetrahedron 1993, 49, 525.
18. (i) Horwell, D. C. TIBTECH 1995, 13, 132.
19. 7. Boden, P. R.; Higgenbottom, M.; Hill, D. R.; Horwell, D. C.: Hughes, J.; Rees, D. C.; Roberts, E.; Singh, L.; Suman-Chauhan, N.; Woodruff, G. N. J. Med. Chem. 1993, 36, 552.
20. 8. Either the (S) or racemic substituted phenylalanines were used as the starting materials. In the case of the racemic phenylalanines (Examples 6-16, 19-26), the diastereomers of I at the final step were separated by reverse phase chromatography.
21. 9. The synthesis of (R)-or (S)-[(2-adamantyloxy)carbonyl]-α-methyltryptophan (2-Adoc-α-Me-Trp-OH) is reported in ref. 6a.
22. 10. Augelli-Szafran, C. E.; Blankley, C. J.; Roth, B. D.; Trivedi, B. K.; Bousley, R. F.; Essenburg, A. D.; Hamelehle, K. L.; Krause, B. R.; Stanfield, R. L. J. Med Chem. 1993, 36, 2943.
23. 11. Crossley, M. J.; Fisher, M. L.; Potter, J. J.; Kuchel, P. W.; York, M. J. J. Chem Soc., Perkin Trans. 1. 1990, 2363.
24. 12. Furukawa, M.; Okawara, T.; Terawaki, Y. Chem. Phar. Bull. 1977, 25, 1319.
25. 13. Davies, S. G.; Ichihara, O. Tetrahedron:Asymmetry 1991, 2, 183.
26. 14. Birchmore, B.; Boden, P. R.; Hewson, G.; Higginbottom, M.; Horwell, D. C.; Ho, Y. P.; Hughes, J.; Hunter, J. C.; Richardson, R. S. Eur. J. Med. Chem. 1990, 25, 53.
27. 15. Horwell, D. C.; Beeby, A.; Clark, C. R.; Hughes, J. J. Med Chem. 1987, 30, 729.
28. 16. Pincus, M. R.; Carty, R. P.; Chen, J.; Lubowsky, J.; Avitable, M.; Shah, D.; Scheraga, H. A.; Murphy, R. B. Proc. Natl. Acad. Sci. U.S.A. 1987, 84, 4821.
29. th SCI-RSC Medicinal Chemistry Symposium; Leeming P. R., Ed.; Royal Society of Chemistry Special Publication No. 65; Royal Society of Chemistry: Letchworth, 1988; p 62.
30. nd, 1979, 33.
31. 18. Eden, J. M.; Higginbotton, M.; Hill, D. R.; Horwell, D. C.; Hunter, J. C.; Martin, K.; Pritchard, M. C.; Rahman, S. S.; Richardson, R. S.; Roberts, E. Eur. J. Med. Chem. 1993, 28, 37.
32. 19. Pleiss, M. A.; Unger, S. H. In Comprehensive Medicinal Chemistry, Vol. 4, Quantitative Drug Design; Ramsden, C. A., Ed.; Pergamon: New York, 1990; pp 561-587.
33. 20. Martin, Y. C. In Quantitative Drug Design: A Critical Introduction, Grunewald G. L., Ed.; Marcel Dekker: New York, 1978.
34. 21. Hansch, C.; Leo, A. Substituent Constants For Correlation Analysis in Chemistry and Biology; Wiley: New York, 1979.
35. 22. Norrington, F. E.; Hyde, R. M.; Williams, S. G.; Wootten, R. J. Med. Chem. 1975, 18, 604.
36. 23. Verloop, A. In IUPAC Pesticide Chemistry, Human Welfare and the Environment; Miyamoto, J. et al., Eds; Pergamon: New York, 1983; pp 339-344.
37. 24. SAS Institute Inc., SAS/STAT User's Guide, Version 6, 4th Ed., Vol. 1 and 2, Cary, NC: SAS Institute Inc., 1989.